Contraception Flashcards

1
Q

The menstrual cycle is regulated by

A

positive and negative feedback in the hypothalamic–pituitary–ovarian axis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Gonadotropin-releasing hormone (GnRH) pulses regulate

A

follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which in turn, regulate the secretion of estrogen and progesterone from the ovary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The menstrual cycle is divided into

A

four phases: follicular, ovulatory, luteal, and menstrual.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Follicular phase: FSH stimulates

A

several follicles to develop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

several follicles to develop

A

estradiol to create negative feedback and decrease FSH levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ovulatory phase: estradiol levels peak

A

and exert positive feedback to induce an LH surge, which facilitates release of the mature ovum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Estrogen promotes proliferation

A

of the endometrium and development of progesterone receptors in the endometrium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Luteal phase:

A

progesterone prevents new follicle development as well as differentiation of the endometrium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If no pregnancy, the

A

corpus luteum degenerates, leading to menstrual bleeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Use the safest, best-tolerated, and most

A

effective method that the patient desires.
Safety
Tolerance
Effectiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Rational Drug Selection

A

Start with absolute contraindications.

Delivery method should be of patient’s choice.

Fine tune based on:
Menstrual pattern
Side-effect profile

Consider:
Patient’s desire for discretion
Timing of subsequent pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Steps in choice and initiation

A

establish rapport
identify those appropriate to receive contraceptive

counseling
assess medical history and contraindication to methods
initiate contraceptive

counseling process
elicit informed preferences for method characteristics
facilitate preference-

concordant decision making
counsel about method initiation and use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

World Health Organization Medical Eligibility Criteria for Contraception Use
US Medical Eligibility Criteria for Conception Use
Provide definitive guidance on safety across a broad range of conditions for different patient populations
Both label contraceptive methods as

A

category 1, 2, 3, or 4 for each identified condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Categories 1 and 2 are considered

A

generally safe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Category 4 methods are

A

contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

For those classified as category 3,

A

the recommendations state that the “method is usually not recommended unless other more appropriate methods are not available or acceptable.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Contraception Methods

A

Combined hormonal contraceptives
Progestin-only contraceptives
Intrauterine devices
Emergency contraceptive pills

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Estrogen has positive effects on

A

bone mass, increases serum triglycerides, and improves ratio of high-density lipoprotein to low-density lipoprotein.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Estrogen stimulates

A

coagulation and fibrinolyticpathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Progesterone increases

A

body temperature and insulin levels.

21
Q

Progesterone may depress

A

the central nervous system

22
Q

Two formulations of estrogen are available in contraceptive

A

ethinyl estradiol and mestranol

23
Q

Progestins are primarily responsible

A

for the contraceptive effect.

24
Q

Progestins exhibit a

A

egative effect in the hypothalamic-pituitary-ovarian axis.

25
Progestins cause atrophy
of the endometrium, preventing implantation.
26
The estrogen component improves
efficacy by suppressing FSH release.
27
Estrogen provides
cycle control
28
Traditional
21 days active drug + 7 days inactive tablets with withdrawal bleed during inactive tablets
29
Extended cycle
84 days of active drug, then 7 days off | Withdrawal bleed once every 3 months
30
Monophasic: same dose
of estrogen and progestin for full cycle
31
Biphasic: vary
the dose of progestin
32
Triphasic: vary the dose
of estrogen, progestin, or both
33
Ortho Evra patch: releases
20 mcg of estrogen and 150 mcg of norelgestromin 
34
Patch applied weekly
for 3 weeks, then 1 week off
35
start patch on
on first day of menses | Can start other days if back up method is used
36
Topical Patch ADR
ADRs similar to OC ADRs
37
Topical Patch increased
failure rate in women weighing more than 198 lb
38
NuvaRing is a
a soft, flexible plastic ring that releases 15 mcg of estrogen and 120 mcg of etonogestrel daily.
39
Ring is placed in the
vagina, left in place for 3 weeks, and then is left off for 1 week.
40
ring has better
Better cycle control and decreased breakthrough bleeding are achieved compared with OC.
41
ring systemic exposure
Systemic exposure to estrogen is lower.
42
Progestin-Only Pills - these are used when
These are used when estrogen is contraindicated
43
Progestin-Only Pills effeict is through
Contraceptive effect is through thickening of cervical mucus and prevention of sperm penetration.
44
Progestin-Only Pills useres have to be diligent
Users have to be diligent about taking dose daily at the same time. If a pill is taken even a few hours late, a back-up method is recommended for the following 48 hours
45
Progestin-Only Pills ADR
ADRs: changing bleeding patterns and breast tenderness are common.
46
Depot medroxyprogesterone acetate (Depo-Provera) is a
long-acting, injectable progestin-only contraceptive.
47
Depot - One injection
One injection is effective in suppressing ovulation for 12 to 13 weeks
48
Depot Advantages
Once every 12 week dosing | Effective
49
Depot - Disadvantages
Spotting, followed by amenorrhea Weight gain Depression Black Box warning: decreased bone density with longer-term use